ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,882Medicare Part D Prescriptions Filled, Including Refills

Rank: 106 out of 1000

$877K Total Retail Price of All Prescriptions

Rank: 82 out of 1000

640 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 640 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

20% of this provider’s 640 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

2% of this provider’s 11,472 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
OMEPRAZOLE 631 443 1 2
HYDROCODONE-ACETAMINOPHEN 527 392 S3 2 1
METFORMIN HCL 501 273 3 8
FUROSEMIDE 471 349 4 7
POTASSIUM CHLORIDE 388 309 5 10
SIMVASTATIN 385 270 6 3
LISINOPRIL 363 211 7 5
LEVOTHYROXINE SODIUM 349 279 8 4
NEXIUM 247 171 9 23
AMLODIPINE BESYLATE 246 220 10 6
MELOXICAM 232 94 11 14
GABAPENTIN 230 169 12 11
ZOLPIDEM TARTRATE 226 158 13 16
TRAMADOL HCL 226 109 13 13
CARVEDILOL 222 186 15 15
PRAVASTATIN SODIUM 207 138 16 12
WARFARIN SODIUM 205 178 17 22
CITALOPRAM HBR 200 167 18 17
LOVASTATIN 200 112 18 41
METOPROLOL SUCCINATE 191 135 20 21
HYDROCHLOROTHIAZIDE 181 117 21 9
SERTRALINE HCL 176 141 22 26
DONEPEZIL HCL 172 152 23 32
PROAIR HFA 169 81 24 50
FLUCONAZOLE 169 113 24 102
GLIMEPIRIDE 159 85 26 34
NAMENDA 158 148 27 43
FENOFIBRATE 158 90 27 55
LISINOPRIL-HYDROCHLOROTHIAZIDE 153 113 29 20
AZITHROMYCIN 147 100 30 36
LOSARTAN-HYDROCHLOROTHIAZIDE 140 89 31 38
FAMOTIDINE 131 96 32 88
CIPROFLOXACIN HCL 125 76 33 46
ATORVASTATIN CALCIUM 118 93 34 18
CYMBALTA 117 69 35 53
AMLODIPINE BESYLATE-BENAZEPRIL 111 82 36 59
SULFAMETHOXAZOLE-TRIMETHOPRIM 111 81 36 70
ATENOLOL 110 89 38 24
ESCITALOPRAM OXALATE 108 73 39 60
BENAZEPRIL HCL 106 93 40 61
METOPROLOL TARTRATE 103 77 41 19
PAROXETINE HCL 97 69 42 63
SINGULAIR 95 34 43 84
CLOPIDOGREL 90 68 44 35
MECLIZINE HCL 90 58 44 80
ROPINIROLE HCL 89 67 46 82
LYRICA 88 55 47 47
RAMIPRIL 88 46 47 77
PREMARIN 88 41 R 47 109
VENTOLIN HFA 87 47 50 83
FENTANYL 87 84 S2 50 100
NOVOLIN R 85 79 52 185
PHENYTOIN SODIUM EXTENDED 81 24 53 115
ALLOPURINOL 81 69 53 31
FLUOXETINE HCL 79 52 55 51
TRIAMCINOLONE ACETONIDE 79 56 55 159
EVISTA 77 77 57 168
CRESTOR 77 63 57 30
ADVAIR DISKUS 76 41 59 65
PANTOPRAZOLE SODIUM 73 34 60 28
TAMSULOSIN HCL 73 40 60 33
MIRTAZAPINE 71 60 62 56
RANITIDINE HCL 69 28 63 37
PLAVIX 68 48 64 49
RISPERIDONE 68 65 64 87
METOCLOPRAMIDE HCL 68 57 64 99
SYMBICORT 66 29 67 149
FLUTICASONE PROPIONATE 66 37 67 40
DILTIAZEM 24HR CD 64 48 69 136
LEVEMIR 63 57 70 179
TRAZODONE HCL 62 56 71 29
METHOCARBAMOL 60 0 R 72 79
DIGOXIN 59 44 73 52
MONTELUKAST SODIUM 59 20 73 132
JANUVIA 58 39 75 85
POLYETHYLENE GLYCOL 3350 57 32 76 69
CLONIDINE HCL 57 38 76 27
LOSARTAN POTASSIUM 57 34 76 25
AMITIZA 56 27 79 276
ONGLYZA 55 48 80 221
LANTUS 54 47 81 68
DIOVAN 53 35 82 67
CARBIDOPA-LEVODOPA 52 52 83 116
ABILIFY 50 35 84 198
ALENDRONATE SODIUM 50 22 84 57
AMOXICILLIN 50 33 84 89
CYCLOBENZAPRINE HCL 50 20 R 84 39
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 6, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.